Clinical Trial Detail

NCT ID NCT03592472
Title A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Xynomic Pharmaceuticals, Inc.
Indications

renal cell carcinoma

Therapies

Pazopanib

Abexinostat + Pazopanib

Age Groups: adult senior

No variant requirements are available.